Pill Identifier App

Clinical Trials Update: Aug. 20, 2008

-- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

If you are aged 18 to 55 and have a confirmed diagnosis of relapsing-remitting multiple sclerosis with at least one relapse in the past 12 months, you may qualify for this study.

The research site is in Round Rock, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.



If you are 18-75 years old, have plaque psoriasis despite at least four months of treatment with etanercept, and have psoriatic target lesions that have a PGA score greater than one at screening, you may qualify for this study.

The research site is in San Diego, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.


Rhinitis, Allergic, Perennial

If your child is aged 6 months to 11 months, has symptoms of allergic rhinitis, and has been treated with antihistamines or is a candidate for such treatment, the child may be eligible for this study.

The research site is located in Albany, Ga.

More information

Please see http://www.centerwatch.com/patient/studies/cat804.html.


Copyright 2008, CenterWatch. All rights reserved.

Posted: August 2008

Recommended for you

View comments